Showing 1 - 4 results of 4 for search 'Shuo Kang', query time: 0.01s Refine Results
  1. 1
    Cost-effectiveness of biomarker-directed toripalimab plus chemotherapy for previously untreated extensive-stage small-cell lung-cancer in China.

    Cost-effectiveness of biomarker-directed toripalimab plus chemotherapy for previously untreated extensive-stage small-cell lung-cancer in China. by Shuo Kang, Shan Zhao, Xiaohui Wang, Zhenhua Pan

    Published 2025-01-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Cost-effectiveness of biomarker-directed toripalimab plus chemotherapy for previously untreated extensive-stage small-cell lung-cancer in China

    Cost-effectiveness of biomarker-directed toripalimab plus chemotherapy for previously untreated extensive-stage small-cell lung-cancer in China by Shuo Kang, Shan Zhao, Xiaohui Wang, Zhenhua Pan

    Published 2025-01-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Cost-effectiveness analysis of pembrolizumab plus chemotherapy versus placebo plus chemotherapy for patients with previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer in China

    Cost-effectiveness analysis of pembrolizumab plus chemotherapy versus placebo plus chemotherapy for patients with previously untreated locally recurrent inoperable or metastatic tr... by Yibing Hou, Shuo Yang, Xiaohui Wang, Shan Zhao, Huanlong Liu, Shuo Kang

    Published 2025-08-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Optimization and Metabolite Profiling of Mycotoxin Enniatin B Biodegradation by <i>Bacillus tequilensis</i>

    Optimization and Metabolite Profiling of Mycotoxin Enniatin B Biodegradation by <i>Bacillus tequilensis</i> by Yaxin Zhang, Xu Wang, Xinyi Liu, Yiying Li, Dantong Feng, Shuo Kang, Yidan Wang, Yang Liu, Xu Su, Shiyu Wei, Zhaoyu Li, Yali Wang, Yongqiang Tian

    Published 2025-02-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: